Novartis Investigative Site

La Tronche 38700

0 studies enrolling now · 5 studies all time

What they study most

Acute Heart Failure, Carcinoma, Non-Small-Cell Lung, Heart Failure With Reduced Ejection Fraction (HF-rEF), Non Small Cell Lung Cancer, Solid Tumors

Studies at this site

• Study of Oral cMET Inhibitor INC280 in Patients With EGFR Wild-type (wt), Advanced Non-small Cell Lung Cancer (NSCLC) (Geometry Mono-1) — Completed
• Study of Efficacy and Safety of Nivolumab in Combination With EGF816 and of Nivolumab in Combination With INC280 in Patients With Previously Treated Non-small Cell Lung Cancer — Stopped early
• Multiple Patient Program to Ensure Access to LCZ696 Treatment to Patients Diagnosed With Heart Failure With Reduced Ejection Fraction (HF-rEF) — NO_LONGER_AVAILABLE
• Study of INC280 in Patients With c-MET Dependent Advanced Solid Tumors — Completed
• Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF — Completed